Open access
Open access
Powered by Google Translator Translator

Nephrology

Complications of renal interventions: a pictorial review of CT findings.

21 Jul, 2021 | 10:24h | UTC

Complications of renal interventions: a pictorial review of CT findings – Insights into Imaging

 


Review: Acute kidney injury.

18 Jul, 2021 | 23:18h | UTC

Acute kidney injury – Nature Reviews Disease Primers (free for a limited period)

 

Commentary on Twitter

 


Pathophysiology of COVID-19-associated acute kidney injury.

16 Jul, 2021 | 10:52h | UTC

Pathophysiology of COVID-19-associated acute kidney injury – Nature Reviews Nephrology

 


Summary: SGLT2 inhibitors and GLP-1 receptor agonists established and emerging indications.

14 Jul, 2021 | 10:56h | UTC

SGLT2 Inhibitors and GLP-1 Receptor Agonists: Indications – American College of Cardiology

Original review: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications – The Lancet (link to abstract – $ for full-text)

Related guideline: SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes – This guidance recommends a risk-based approach, advising against starting SGLT-2 inhibitors or GLP-1 receptor agonists in patients with three or fewer cardiovascular risk factors and without established CVD or CKD.

 


A UK expert consensus approach for managing symptomatic arteriovenous fistula (AVF) stenosis in hemodialysis patients.

14 Jul, 2021 | 10:55h | UTC

A UK Expert Consensus Approach for Managing Symptomatic Arteriovenous Fistula (AVF) Stenosis in Haemodialysis Patients – CardioVascular and Interventional Radiology

 


FDA Safety Alert: hydroxyethyl starch products should not be used unless adequate alternative treatment is unavailable.

14 Jul, 2021 | 10:48h | UTC

Labeling Changes on mortality, kidney injury, and excess bleeding with hydroxyethyl starch products – U.S. Food and Drug Administration

Commentary: FDA Piles on New Warnings for Blood Volume Expanders – MedPage Today (free registration required)

Related: Hydroxyethyl-starch Solutions (HES) Should no Longer be Used – European Medicines Agency AND Randomized Trial: Hydroxyethyl Starch vs. Saline for Volume Replacement Therapy in High-Risk Patients Undergoing Major Abdominal Surgery AND Systematic Review: Colloids vs Crystalloids for Fluid Resuscitation in Critically Ill People

 


2021 ACR Guideline for the Management of ANCA–Associated Vasculitis.

9 Jul, 2021 | 10:09h | UTC

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis – Arthritis & Rheumatology

 


Systematic Review: Altered dietary salt intake for people with chronic kidney disease.

9 Jul, 2021 | 09:52h | UTC

Altered dietary salt intake for people with chronic kidney disease – Cochrane Library

Summary: Altered dietary salt intake for adults with chronic kidney disease – Cochrane Library

 

Commentary on Twitter

 


M-A: Incidence and Relapse of Idiopathic Nephrotic Syndrome.

7 Jul, 2021 | 08:37h | UTC

Incidence and Relapse of Idiopathic Nephrotic Syndrome: Meta-analysis – Pediatrics (link to abstract – $ for full-text)

 


Acute kidney injury in the critically ill: an updated review on pathophysiology and management.

5 Jul, 2021 | 01:49h | UTC

Acute kidney injury in the critically ill: an updated review on pathophysiology and management – Intensive Care Medicine

 

Commentary on Twitter

 


Podcast | Evaluation and management of hypercalcemia.

29 Jun, 2021 | 09:51h | UTC

#281 Hypercalcemia: Calci-fun! with Dr. Carl Pallais – The Curbsiders

 


RCT: Similar outcomes with mycophenolate mofetil vs. azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression.

29 Jun, 2021 | 09:50h | UTC

Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial – PLOS One

 


Guideline synopsis: management of blood pressure in patients with chronic kidney disease not receiving dialysis.

22 Jun, 2021 | 10:00h | UTC

Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline – Annals of Internal Medicine

Original guideline: KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Commentary: Guideline issued on blood pressure management in CKD – ACP Internist

 


M-A: Among patients with kidney failure treated with dialysis, mineralocorticoid receptor antagonists reduce cardiovascular and all-cause mortality without increasing the risk of hyperkalemia.

15 Jun, 2021 | 08:53h | UTC

Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

14 Jun, 2021 | 08:27h | UTC

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup – Critical Care

 


The furosemide stress test: current use and future potential.

11 Jun, 2021 | 08:12h | UTC

The furosemide stress test: current use and future potential – Renal Failure

 


Cohort study: the use of potentially inappropriate medications in adults with chronic kidney disease is common and linked to increased risk of hospitalization, mortality, and falls.

11 Jun, 2021 | 08:11h | UTC

Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study – American Journal of Kidney Diseases (link to abstract – $ for full-text)

 

Commentary on Twitter

 


RCT: Among patients with ANCA-associated vasculitis without severe glomerulonephritis or alveolar hemorrhage treated with Rituximab, a reduced-dose glucocorticoids regimen (prednisolone 0.5 mg/kg/d) was noninferior to a high-dose glucocorticoid regimen (prednisolone 1 mg/kg/d) for the induction of disease remission.

4 Jun, 2021 | 10:25h | UTC

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial – JAMA

 


ANCA-Associated Vasculitis: An Update.

4 Jun, 2021 | 10:23h | UTC

ANCA-Associated Vasculitis: An Update – Journal of Clinical Medicine

 


Diagnosis and management of diabetes insipidus for the internist: an update

4 Jun, 2021 | 10:22h | UTC

Diagnosis and management of diabetes insipidus for the internist: an update – Journal of Internal Medicine

 


Consensus report: Postoperative acute kidney injury in adult non-cardiac surgery.

25 May, 2021 | 08:34h | UTC

Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative – Nature Reviews Nephrology

Related review: The incidence, risk, presentation, pathophysiology, treatment, and effects of perioperative acute kidney injury – Canadian Journal of Anesthesiology

 


#ACC21 – RCT: Among patients with resistant hypertension, ultrasound renal denervation resulted in a modest improvement in systolic BP (–4.5 mm Hg) vs. sham procedure.

24 May, 2021 | 08:28h | UTC

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary: Renal Denervation for Resistant Hypertension Is Not Back on Track – “A systolic blood pressure (SBP) reduction of 4.5 mm Hg is not good enough—for an invasive procedure”. – Medscape (free registration required)

 


SPRINT Trial final report: targeting a systolic BP of less than 120 mm Hg in patients at increased CV risk is associated with improved CV and mortality outcomes but increases the risk of serious adverse events.

20 May, 2021 | 08:36h | UTC

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control – New England Journal of Medicine

Commentary: Final results of SPRINT study confirm controlling blood pressure critically important in preventing heart disease and stroke – Cleveland Medical Center

 


ESC Comprehensive review: Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease.

20 May, 2021 | 08:26h | UTC

Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

 

Commentary on Twitter

 


Fluid-induced harm in the hospital: look beyond volume and start considering sodium. From physiology towards recommendations for daily practice in hospitalized adults.

19 May, 2021 | 08:32h | UTC

Fluid-induced harm in the hospital: look beyond volume and start considering sodium. From physiology towards recommendations for daily practice in hospitalized adults – Annals of Intensive Care

 


Stay Updated in Your Specialty

No spam, just news.